Zeng Li
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
-
- Computational Drug Discovery Methods
Papers in
-
- Phenothiazines and Benzothiazines Synthesis and Activities 4
- Phosphodiesterase function and regulation 3
- Pharmacology 13
- Cholinesterase and Neurodegenerative Diseases 12
- Co-authors
- Mingfei Wu (7 shared papers)Xiao‐Ming Meng (7 shared papers)Cheng Huang (4 shared papers)Min Wang (3 shared papers)Taotao Ma (3 shared papers)Hai-Di Li (4 shared papers)Shuai Shi (2 shared papers)Jun Li (4 shared papers)
- Journals
- European Journal of Medicinal Chemistry (9 papers)Chemico-Biological Interactions (5 papers)International Immunopharmacology (4 papers)Molecules (4 papers)Aesthetic Plastic Surgery (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zeng Li
80 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 110
- Pharmacology 167
- Computational Theory and Mathematics 152
- Nephrology 61
- Pharmacology 56
- Organic Chemistry 193
Countries citing papers authored by Zeng Li
This map shows the geographic impact of Zeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeng Li more than expected).
Fields of papers citing papers by Zeng Li
This network shows the impact of papers produced by Zeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeng Li. The network helps show where Zeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 81 | |
| 2 | 2020 | 76 | |
| 3 | 2023 | 60 | |
| 4 | 2011 | 47 | |
| 5 | 2020 | 47 | |
| 6 | 2011 | 44 | |
| 7 | Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy. | 2003 | 43 |
| 8 | 2021 | 42 | |
| 9 | 2017 | 32 | |
| 10 | 2017 | 32 | |
| 11 | 2016 | 31 | |
| 12 | 2021 | 28 | |
| 13 | 2022 | 28 | |
| 14 | 2012 | 27 | |
| 15 | 2019 | 27 | |
| 16 | 2020 | 27 | |
| 17 | 2022 | 27 | |
| 18 | 2014 | 24 | |
| 19 | 2020 | 22 | |
| 20 | 2018 | 20 |
About Zeng Li
Zeng Li is a scholar working on Molecular Biology, Pharmacology, Computational Theory and Mathematics, Organic Chemistry and Immunology, having authored 84 papers that have together received 1.2k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (12 papers), Cholinesterase and Neurodegenerative Diseases (12 papers), Alzheimer's disease research and treatments (5 papers), Synthesis and biological activity (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Peptidase Inhibition and Analysis (4 papers), Quinazolinone synthesis and applications (4 papers) and Phosphodiesterase function and regulation (3 papers). The work is most often cited by research in Pharmacology (167 citations), Computational Theory and Mathematics (152 citations), Nephrology (61 citations), Pharmacology (56 citations) and Organic Chemistry (193 citations). Zeng Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Mingfei Wu, Xiao‐Ming Meng, Cheng Huang, Min Wang, Taotao Ma, Hai-Di Li, Shuai Shi, Jun Li, Tao Xu and Xingyi Li. Their work appears in journals such as European Journal of Medicinal Chemistry, Chemico-Biological Interactions, International Immunopharmacology, Molecules and Aesthetic Plastic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.